INVISIBLU International LLC Issues Voluntary Nationwide Recall Of Continuum Labs Lgd-4033 Due To Product Containing LGD-4033 (Ligandrol), An Investigational Drug Not Approved For Use

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: INVISIBLU International LLC Issues Voluntary Nationwide Recall Of Continuum Labs Lgd-4033 Due To Product Containing LGD-4033 (Ligandrol), An Investigational Drug Not Approved For Use

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

INVISIBLU International LLC Issues Voluntary Nationwide Recall Of Continuum Labs Lgd-4033 Due To Product Containing LGD-4033 (Ligandrol), An Investigational Drug Not Approved For Use

04/05/2016 09:09 AM EDT

Invisiblu International LLC is voluntarily recalling one lot of Continuum Labs LGD-Xtreme, 3 mg to the retail and consumer level. The product has been found to contain LGD-4033 Ligandrol.

For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? Please visit subscriberhelp.govdelivery.com
• Other inquiries? webmail@xxxxxxxxxx

---

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332)